Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis

Arthritis Care & Research
M RudwaleitAtul Deodhar

Abstract

Axial spondyloarthritis (axial SpA) is characterized by inflammation of the spine and sacroiliac joints and can also affect extraarticular sites, with the most common manifestation being uveitis. Here we report the incidence of uveitis flares in axial SpA patients from the RAPID-axSpA trial, including ankylosing spondylitis (AS) and nonradiographic (nr) axial SpA. The RAPID-axSpA (NCT01087762) trial is double-blind and placebo-controlled to week 24, dose-blind to week 48, and open-label to week 204. Patients were randomized to certolizumab pegol (CZP) or placebo. Placebo patients entering the dose-blind phase were re-randomized to CZP. Uveitis events were recorded on extraarticular manifestation or adverse event forms. Events were analyzed in patients with/without history of uveitis, and rates reported per 100 patient-years. At baseline, 38 of 218 CZP-randomized patients (17.4%) and 31 of 107 placebo-randomized patients (29.0%) had past uveitis history. During the 24-week double-blind phase, the rate of uveitis flares was lower in CZP (3.0 [95% confidence interval (95% CI) 0.6-8.8] per 100 patient-years) than in placebo (10.3 [95% CI 2.8-26.3] per 100 patient-years). All cases observed during the 24-week double-blind phase were...Continue Reading

References

Jun 19, 2001·Archives of Ophthalmology·R M SchiffmanS M Whitcup
Oct 2, 2007·Arthritis and Rheumatism·Lyndell L LimJames T Rosenbaum
May 26, 2009·Annals of the Rheumatic Diseases·J SieperB Freundlich
Aug 25, 2011·Seminars in Arthritis and Rheumatism·Daniel WendlingUNKNOWN CRI
Apr 4, 2012·Nature Reviews. Rheumatology·James T Rosenbaum, Holly L Rosenzweig
Oct 23, 2012·Rheumatic Diseases Clinics of North America·Irene E van der Horst-BruinsmaRobert B M Landewé
Dec 12, 2012·Therapeutic Advances in Musculoskeletal Disease·Irene E van der Horst-Bruinsma, Michael T Nurmohamed
Aug 29, 2013·Mediators of Inflammation·Daniel Sánchez-CanoNorberto Ortego-Centeno
Oct 18, 2014·Ocular Immunology and Inflammation·Victor LlorençAlfredo Adán

❮ Previous
Next ❯

Citations

Jul 2, 2016·Expert Opinion on Biological Therapy·Julianna DesmaraisAtul Deodhar
Oct 6, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Emma D Deeks
Oct 18, 2016·Ocular Immunology and Inflammation·Julie GueudryBahram Bodaghi
Apr 5, 2017·Current Opinion in Rheumatology·James T Rosenbaum
Apr 24, 2018·Expert Opinion on Biological Therapy·Alexis JonesPedro M Machado
Dec 1, 2017·Ophthalmology and Therapy·Srilakshmi M SharmaKanmin Xue
Jan 15, 2017·Annals of the Rheumatic Diseases·Désirée van der HeijdeJürgen Braun
Aug 28, 2018·Current Opinion in Ophthalmology·Gurdeep Jhaj, Laura J Kopplin
Dec 26, 2018·Internal Medicine Journal·Amruta Trivedi, Constance Katelaris
Jan 10, 2020·Expert Review of Clinical Immunology·Maria EspositoMaria Concetta Fargnoli
Jul 24, 2020·Expert Review of Clinical Immunology·Carla GaggianoClaudia Fabiani
May 21, 2019·Current Opinion in Rheumatology·Sruthi Arepalli, James T Rosenbaum
Jun 9, 2018·Zeitschrift für Rheumatologie·M D BeckerM Weber
Jun 9, 2020·Frontiers in Pharmacology·Rodrigo A ValenzuelaCristhian A Urzua
Aug 28, 2020·Gut·Thomas GreuterStephan R Vavricka
Sep 24, 2020·Therapeutic Advances in Musculoskeletal Disease·Judith RademacherUwe Pleyer
Oct 7, 2017·Current Opinion in Rheumatology·Leonieke J J van MensDominique L P Baeten
Aug 16, 2017·Zeitschrift für Rheumatologie·M RudwaleitA Heiligenhaus
Nov 9, 2018·BioMed Research International·Martina BiggioggeroEnnio Giulio Favalli
Mar 17, 2020·Advances in Rheumatology·Gustavo Gomes ResendePercival Degrava Sampaio-Barros
Aug 23, 2020·Indian Journal of Ophthalmology·S BalamuruganKirandeep Kaur
Jan 23, 2021·Asia-Pacific Journal of Ophthalmology·Lisia Barros FerreiraJustine R Smith
Nov 12, 2020·Journal of Clinical Medicine·Mathilde LeclercqDavid Saadoun
Oct 17, 2020·Seminars in Arthritis and Rheumatism·Alejandro Gómez-GómezUNKNOWN Spanish Society of Ocular Inflammation (SEIOC)
Jun 14, 2020·Joint, Bone, Spine : Revue Du Rhumatisme·Philippe Goupille, Daniel Wendling
Jun 22, 2021·Frontiers in Immunology·Angela CeribelliCarlo Selmi
Nov 20, 2021·Frontiers in Pharmacology·Qi JiangWenru Su
Nov 20, 2021·Rheumatology and Therapy·Sneha Patel, Anand Kumthekar
Oct 27, 2020·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Jessica A Walsh, Marina Magrey

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01087762

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.